Comparison |
| Application |
Immunoassay Reagent | Molecular Reagent | General Chemistry Reagent |
| CLIA Classification |
CLIA Non-Waived | | |
| CLIA Classified |
CLIA Non-Waived | | |
| For Use With |
For BD Viper Instrument | For BD Viper Instrument | For ACE Axcel / ACE Alera Clinical Chemistry Systems |
| Number of Tests |
1,152 Tests | 1,152 Tests | 450 Tests |
| Product Dating |
McKesson Acceptable Dating: we will ship >= 30 days | McKesson Acceptable Dating: we will ship >= 30 days | McKesson Acceptable Dating: we will ship >= 90 days |
| Sample Type |
Urine / Endocervical Swab / Vaginal Swab / Male Urethral Swab Sample | Urine / Endocervical Swab / Vaginal Swab / Male Urethral Swab Sample | Serum / Plasma Sample |
| Specialty |
Immunoassay | Molecular | General Chemistry |
| Storage Requirements |
| | Requires Refrigeration |
| Test Category |
Sexual Health | Sexual Health | General Chemistry |
| Test Method |
Amplified DNA Assay | | |
| Test Name |
Chlamydia Trachomatis / Neisseria Gonorrhoeae (CT / NG) | Neisseria Gonorrhoea (NG) | Alanine Aminotransferase (ALT) |
| Test Type |
Infectious Disease | DNA Amplification / Detection | Hepatic |
| UNSPSC Code |
41116011 | 41116011 | 41116105 |
| Volume |
1,152 Tests | | |
| Country of Origin |
United States | United States | United States |
| Features and Benefits |
- Qualitative detection of Chlamydia trachomatis DNA in clinician-collected female endocervical and male urethral swab specimens, patient-collected vaginal swab specimens (in a clinical setting), and male and female urine specimens
|
- Qualitative detection of Neisseria gonorrhoeae DNA in clinician-collected female endocervical and male urethral swab specimens, patient-collected vaginal swab specimens (in a clinical setting), and male and female urine specimens
|
- For the quantitative determination of alanine aminotransferase activity in serum and lithium heparin plasma
|
